Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

计划入组 65 人 · 首次发布于 2020 年 6 月 5 日

Sanofi Initiates Phase 1 Trial of Oral STAT6 Degrader SAR448272, Triggering $10M Milestone Payment to Nurix